Blue-Blocking Glasses as Adjunct to Lithium in Preventive Treatment for Bipolar Disorder
This study was presented by Drs Tone Elise Henriksen, and Tuva Maria Martinussen from the Valen Hospital, Fonna Hospital Trust, at the 2024 Annual Meeting
This study was presented by Drs Tone Elise Henriksen, and Tuva Maria Martinussen from the Valen Hospital, Fonna Hospital Trust, at the 2024 Annual Meeting
A review on allopregnanolone agonists was presented by Drs Octavian Vasiliu, Andrei Gabriel Mangalagiu, et al., from the University Emergency Central Military Hospital Carol Davila
A review on a novel antidepressant was presented by Drs Daniel Vasile, Octavian Vasiliu, Diana Vasiliu from the University of Medicine and Pharmacy Carol Davila,
A study on the complex relationship between mood disorders and metabolic conditions was presented by Drs Aniqa Tabassum, Joshua Di Vincenzo, et al., from the
The trial results exploring the potential of virtual reality (VR) in improving mood and psychosis spectrum disorders was presented by Dr Andreas Jespersen et al.,
A study on the relationship between intracortical myelin (ICM) changes and relapse in individuals with bipolar I disorder (BD-I) was presented by Drs Benicio N.
A study on the genetic-environmental and cerebral underpinnings of bipolar disorder and major depressive disorder was presented by Dr Eleonora Maggioni, et al., from Politecnico
A systematic review and meta-analysis on the treatment of bipolar disorder (BDII) was presented by Dr Mette Fredskild, et al., from the Copenhagen Affective Disorders
A new study on the optimal lithium dosing schedule for patients with bipolar disorder was presented by Drs Philipp Ritter, David Cousins, Katinka Edelmann from
The study was presented by Dr Marco Solmi from the University of Ottawa, Canada at the 2024 Annual Meeting of the International Society for Bipolar